ITGAX and systemic lupus erythematosus: The novelty here resides in highlighting the increased frequency of CD11c-CXCR5- B cells and DN3 B cells in SLE and the strong association of the percentage of DN3 B cells and of CD19 MFI with SLE disease activity.